Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis
- Conditions
- Chorioamnionitis
- Registration Number
- NCT00299637
- Lead Sponsor
- Hadassah Medical Organization
- Brief Summary
This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.
- Detailed Description
This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.
MCA flow parameters will be evaluated during labor of women with and wthout chorioamnionitis
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 34
Inclusion Criteria
- women giving birth week 37-42
- healthy
- one fetus
Exclusion Criteria
- more than one fetus
- IUGR
- illness or damage to fetus
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link chorioamnionitis to fetal middle cerebral artery blood flow changes?
Are there specific biomarkers that correlate with altered fetal MCA blood flow in chorioamnionitis cases?
How does clinical chorioamnionitis affect fetal cerebral autoregulation compared to healthy pregnancies?
What are the long-term neurodevelopmental outcomes for fetuses with MCA flow changes due to maternal chorioamnionitis?
Can Doppler ultrasound parameters in MCA predict adverse neonatal outcomes in chorioamnionitis-affected pregnancies?
Trial Locations
- Locations (1)
Haddasah Medical Organization
🇮🇱Jerusalem, Israel
Haddasah Medical Organization🇮🇱Jerusalem, IsraelDavid MankutaPrincipal Investigator